DLP® 96428Recalls & reported problems
Medtronic, Inc. · CANNULA 96428 FEMORAL VEN 28FR 4PK 17L · Class 2
All models of DLP (151)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 20613994556701), received between Feb 7, 2023 and Feb 27, 2023 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Component Missing” (2 reports).
1 other recall cover devices cleared under the same FDA submission (K875353); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Component Missing2
- Obstruction of Flow1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 27, 2023Component Missing; Component Missing
MEDTRONIC RECEIVED INFORMATION THAT DURING USE, OF A DLP FEMORAL VENOUS CANNULA, IT WAS REPORTED THAT THE CANNULA HAD RELIEF PROBLEMS AND AFTER REMOVAL OF THE CANNULA IT BECAME APPARENT THAT THE LATERAL PERFORATIONS WERE COMPLETELY ABSENT. THERE WAS NO ADVERSE PATIENT EFFECT REPORTED WITH THIS EVENT. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE DEVICE WAS INSPECTED PRIOR TO USE BUT NOT IN DETAIL. IT WAS STATED THAT THERE WAS NO DAMAGE TO THE CANNULA BODY OR TIP. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE FLOW WAS LOWER THAN EXPECTED. THE CUSTOMER STATED THAT THE HOLES WERE MISSING FROM THE CANNULA. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE CUSTOMER WAS ABLE TO GET A SUFFICIENT DRAINAGE IN TOTAL BY INSERTING ANOTHER CANNULA VIA THE SUPERIOR VENA CAVA. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE SAME INSERTION SITE WAS NOT USED TO INSERT THE SECOND CANNULA. THE CUSTOMER CONFIRMED THAT THERE WERE NO ADVERSE PATIENT EFFECTS BECAUSE OF THIS ISSUE. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE INSERTION SITE WAS SUTURED WITH COMMON SUTURES. NO CLOSURE DEVICE WAS USED. A SECOND CANNULA WITH NO PERFORATIONS/HOLES WAS RETURNED TO THE ANALYSIS LAB. THIS SEC
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16443381 ↗InjuryFeb 7, 2023Component Missing; Obstruction of Flow; Component Missing; Obstruction of Flow
MEDTRONIC RECEIVED INFORMATION THAT DURING USE, OF A DLP FEMORAL VENOUS CANNULA, IT WAS REPORTED THAT THE CANNULA HAD RELIEF PROBLEMS AND AFTER REMOVAL OF THE CANNULA IT BECAME APPARENT THAT THE LATERAL PERFORATIONS WERE COMPLETELY ABSENT. THERE WAS NO ADVERSE PATIENT EFFECT REPORTED WITH THIS EVENT. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE DEVICE WAS INSPECTED PRIOR TO USE BUT NOT IN DETAIL. IT WAS STATED THAT THERE WAS NO DAMAGE TO THE CANNULA BODY OR TIP. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE FLOW WAS LOWER THAN EXPECTED. THE CUSTOMER STATED THAT THE HOLES WERE MISSING FROM THE CANNULA. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE CUSTOMER WAS ABLE TO GET A SUFFICIENT DRAINAGE IN TOTAL BY INSERTING ANOTHER CANNULA VIA THE SUPERIOR VENA CAVA. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE SAME INSERTION SITE WAS NOT USED TO INSERT THE SECOND CANNULA. THE CUSTOMER CONFIRMED THAT THERE WERE NO ADVERSE PATIENT EFFECTS BECAUSE OF THIS ISSUE. A SECOND CANNULA WITH NO PERFORATIONS/HOLES WAS RETURNED TO THE ANALYSIS LAB.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16311613 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K875353. One submission often covers many models, so check the product and lot details in each record.
- Z-1914-2015 · Jun 12, 2015 · TerminatedMedtronic DLP Femoral Arterial Cannula, models 57414, 57417, and 57421, and DLP Femoral Cannula Replacement Kit, Models 96017 and 96021. Sterilized using Ethylene Oxide. The can
Other CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS devices
- DLP™ 77010Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass1 recall154 reports
- EOPA™ 77422Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls19 reports
- DLP™ 77008Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls9 reports
- NA HY11W65R1Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls8 reports
- DLP® 12113Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls6 reports
- DLP® Aortic Root Cannula with Flow-Guard™ 11012Medtronic, Inc. · CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS2 recalls5 reports
- EOPA™ 77622Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls4 reports
- NA HY11R00R6Medtronic, Inc. · Catheter, cannula and tubing, vascular, cardiopulmonary bypass2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page